MTOR and systemic lupus erythematosus: Several other approaches have been shown to block mTOR activation in animal models and T cells derived from the blood of SLE patients, including the blocking of S1P receptors, antioxidants, and calmodulin kinase type II and type IV inhibitors [44,45,46,47].